Sasineprocel

N/A

Report date: 2026/03/20 20:03:07

Base Information

Drug NameSasineprocel
Drug Alias NameA9-line dopamine neuron therapy(Aspen Neuroscience)ANPD-001
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionDopaminergic cell replacements
TargetsNot applicable
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAspen Neuroscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesMytosAspen Neuroscience Inc
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A